AI GxP validation for regulated life sciences
Products

Products That Own The Workflow

Four AI-native platforms for validation, clinical documentation, quality management and study intelligence. All purpose-built for regulated Life Sciences.

Quick chat on WhatsAppHuman review at every gatePart 11 readyISO 9001 & 27001 certified
In short

Cybroscape builds four AI products for regulated life sciences. GxP Copilot produces the validation or qualification package for a system, instrument or piece of equipment. TraceDraft produces clinical documents — study reports, protocols, safety narratives, clinical evaluation reports — with every statement traceable to its source. Cybroscape eQMS runs the quality system as one connected chain from deviation to CAPA to change. Study Intelligence brings every lab, CRO and biorepository into one view of each study. In all four, AI drafts and qualified people decide and sign.

Trusted by life sciences teams worldwide

GSK
Karolinska Institutet
Mercy Health
3Analytics
TriDS Validation
Excelra
Ceban Pharmaceuticals
Prothiya
Batavia Biosciences
Codern Pharma
Hexaware
Validation

GxP Copilot

Produces the validation or qualification package for a system, instrument or piece of equipment.

  • Full GAMP 5 package drafted from your URS
  • Risk-based, CSA-first test strategy
  • Part 11 signatures and a hash-chained audit trail

GxP Copilot drafts the validation package for pharma, biotech, medical device, CRO and diagnostics teams, so their validation leads spend their time reviewing and deciding rather than writing. A short intake and your requirements produce a GAMP 5 Second Edition-aligned package, sized to per-requirement risk under FDA's Computer Software Assurance guidance. Your validation leads review, refine and sign; the platform handles drafting, traceability and evidence assembly. Every action is recorded in a tamper-evident audit trail with 21 CFR Part 11 electronic signatures.

GxP Copilot 3.0 validation project overview: documents approved, testing progress and inspection readiness
Clinical documentation

TraceDraft

Produces clinical and regulatory documents where every sentence traces back to source data.

  • CSRs, protocols, safety narratives and CERs
  • Every claim linked to its source
  • Bring your own AI model

Cybroscape TraceDraft drafts regulated documents from your own sources: ICH E3 clinical study reports, CTD Module 2.5 and 2.7 clinical summaries, ICSR case narratives (E2B(R3) and CIOMS I), computerised system validation protocols (IQ/OQ/PQ) and SOPs. It can also analyse any document you upload, such as a finished CSR or a guideline, against the structure it should follow. Sources are read by code, not by a model, and every sentence must cite the source fact behind it; a sentence whose numbers or dates do not match its sources is repaired once or removed. Tables, title pages and traceability are built by code. Medical writers and reviewers approve each section in a review queue, a document can only be locked once every section is approved, and every action lands in a hash-chained audit trail.

TraceDraft clinical study report with a source citation on every value
Quality management

Cybroscape eQMS

Runs the quality system: documents, deviations, CAPA, change control, training, suppliers and audits, connected end to end.

  • Deviation to CAPA to change to SOP in one chain
  • Quality Copilot drafts, QA decides and signs
  • Device pack for ISO 13485 and EU MDR

Most quality systems store records. Cybroscape eQMS also connects them. A deviation opens its investigation, the investigation feeds the CAPA, the CAPA raises the change, and the change opens the SOP revision and tells validation what needs re-testing, each step with its own review and signature. Quality Copilot drafts deviation descriptions, investigation summaries, CAPA plans and SOP updates from the facts already in the system, so QA spends its time deciding rather than typing. Built for 21 CFR Part 11 and EU Annex 11, with AI governance designed around the draft EU GMP Annex 22.

Cybroscape eQMS quality dashboard
Study intelligence

Study Intelligence

Brings sample, biomarker, operations and vendor data from every CRO and lab into one view of each study.

  • Master sample inventory with consent and custody
  • Study agents that cite their sources
  • Exceptions raised before they become findings

A clinical programme spreads its data across many hands: central and specialty labs hold the samples and assay results, CROs hold the site and visit data, biorepositories hold the inventory, and consent sits in yet another system. Study teams spend their week reconciling these sources by spreadsheet. Study Intelligence brings them together, matches samples to subjects, visits and consent, harmonises biomarker data into one model, and keeps study operations visible across vendors. Study agents answer questions like 'which samples are at risk of missing their stability window?' with the records cited, and raise exceptions (a consent withdrawal with samples still in storage, a shipment that never arrived, a visit with no matching sample) as they happen.

Study Intelligence study overview
Choose

Which one you need depends on your bottleneck

These solve different problems for different buyers.

If your bottleneck is…ChooseWhat you get
Getting systems validated and keeping them validatedGxP CopilotValidation package, live traceability, audit trail
Writer capacity for CSRs, protocols and narrativesTraceDraftSource-traced clinical documents, reviewer workflow
Deviations, CAPAs and SOP changes that never quite closeCybroscape eQMSOne connected quality system with AI drafting
Samples and study data scattered across CROs and labsStudy IntelligenceOne view of each study, agents that cite sources
More than one of theseCombine themThe same approach to records, review and signatures in each

These solve different problems for different buyers. If the thing holding you up is getting systems validated and keeping them that way — a LIMS going live, an inspection finding, a vendor upgrade that broke validated status, an estate inherited through acquisition — that is GxP Copilot.

If the constraint is clinical writing capacity — CSR turnaround limited by writer headcount, a narrative queue that appears after database lock, a CER that has aged past what a notified body will accept — that is TraceDraft. Neither requires the other, and most organisations start with one.

Shared foundation

What they share, and why it matters

Both are built on the same position: AI drafts, qualified humans decide and sign.

AI drafts, humans sign

Qualified people decide and sign every deliverable.

Deterministic risk

Classification and risk are computed, never generated.

Traceable to source

AI drafts are grounded in your own inputs and marked for review.

Part 11 by design

E-signatures and a tamper-evident audit trail.

Both are built on the same position: AI drafts, qualified humans decide and sign. Classification, risk and release verdicts are computed from confirmed facts rather than generated, so the same inputs always give the same answer and an inspector gets a derivation rather than a model output.

Both keep a hash-chained, tamper-evident audit trail and freeze approved records. GxP Copilot adds Part 11 electronic signatures with re-authentication, the meaning of the signature recorded and author separated from approver; TraceDraft records every section approval against a named reviewer and locks a document only when every section is approved.

Guardrails

Where the AI is deliberately not allowed

The most important design decision in both products is where the model does not operate. Risk scores, GAMP categories, USP <1058> groups, traceability coverage and release verdicts are computed in code from stated rules. "The model assessed it" is not an answer an inspector accepts, and no amount of model quality makes it one.

That line is also what the draft EU Annex 22 expects: a qualified person remains accountable for any decision affecting product quality or patient safety. It is not a constraint we work around — it is the condition under which AI belongs in these workflows at all.

AI not usedRisk scores
AI not usedGAMP category
AI not usedRelease decisions
AI not usedApprovals and signatures
GxP Copilot audit trail with hash chain verification
Delivery leads includedProduct and team, one partner
Delivery

Product and delivery, not one or the other

Software alone rarely solves a validation or documentation backlog, because the constraint is usually a mix of tooling, procedure and available expertise. Our services practice runs the same work as an engagement, with or without the products, so you are not forced to adopt a platform to get a package delivered.

FAQ

Common questions

Prefer to talk first? Chat with us on WhatsApp or book a call with an expert.

What is the difference between GxP Copilot and TraceDraft?

GxP Copilot validates systems: it produces the computer system validation or equipment qualification package for a LIMS, an instrument, a piece of equipment or a SaaS application. TraceDraft writes clinical documents: study reports, protocols, safety narratives and clinical evaluation reports. Different buyers, different deliverables, the same underlying discipline about provenance and human approval.

Which one do we need?

If your bottleneck is getting systems validated and keeping them validated, that is GxP Copilot. If it is clinical writing capacity — CSR turnaround, narrative volume, CER updates — that is TraceDraft. Organisations that run both typically arrive at one first and adopt the second once the compliance posture has been tested in practice.

Do the products require each other?

No. Each is used independently and most customers use one. They share the same approach to source traceability and a hash-chained audit trail.

Can we use our own AI model?

The AI provider is swappable rather than fixed. This matters in regulated environments where a model change is a change to a validated system — you need to know whose model you are running, to pin it, and to be told before it changes.

What do both products refuse to do?

Neither lets AI make a GxP-critical decision. In GxP Copilot, classification, risk scoring and release verdicts are computed from confirmed facts rather than generated, and approval is a re-authenticated electronic signature. In TraceDraft, every sentence must cite its source and nothing is locked until a named reviewer has approved every section. AI drafts, retrieves and proposes; a qualified human decides.

See your own URS become a validation package.

One real requirements document. We show you the draft package built from it, and you keep it either way.

  • We reply within one business day
  • We run your URS live on the call
  • You get a clear plan for your system
Chat on WhatsApp

Book a demo

Four fields. The right specialist replies within one business day.

Your details stay private. We never share them.